FEB 18, 2017 08:38 AM PST

Tagging Unmarked Cancer Cells for Targeted Therapy

WRITTEN BY: Xuan Pham

Using small-molecule sugars, scientists successfully made artificial tags for cancer cells that otherwise blended in with healthy cells. The technique, researchers say, will allow for precise and targeted therapies, especially for cancers that previously evaded treatment because they were good at hiding.

Receptors are small molecular protein tags, often found on the surface of cells. Through the binding of other small molecules, receptors can transmit signals from the outside of the cell to the inside of the cell. Aside from cellular communication, receptors are extremely useful in medicine, as these protein tags allow scientists to target specific cells. For example, many drugs are designed to act on cells that express certain receptors on their surface, while leaving other non-specific cells unharmed.

In the case of some cancers, the cells outsmart targeted therapies by the simple virtue of lacking cell surface receptors. The classic example of receptor-negative cancer is triple-negative breast cancer, which lack three receptors: estrogen, progesterone, and the epidermal growth factor receptor 2 (HER2). Absence of receptors makes the cells unidentifiable to drugs, and these cancers typically don’t respond to therapy.

To mark these cells, researchers from the University of Illinois at Urbana-Champaign and China collaborated on a technique that selectively label cancer cells. In particular, they inserted sugar molecules called azides into cells. Cells that are cancerous then metabolize the sugars, causing the expression of receptors on their surface. These receptors are specific to another molecule called DBCO.

"It's very much like a key in a lock. They are very specific to each other. DBCO and azide react with each other with high specificity. We call it click chemistry. The key question is, how do you put azide just on the tumor?" explained Dr. Jianjun Cheng, the study’s senior author.

To ensure that only azide molecules are inserted and metabolized by cancer cells, Cheng’s team modified the sugar with an enzyme that can only be cleaved by cancer cells. In healthy cells, the sugar has no effect.

With receptors expressed on the surface of cancer cells, drug-loaded DBCO molecules can then be introduced. The lock-and-key mechanism ensures only the cancer cells would receive the drug.

"For the first time, we labeled and targeted tumors with small molecule sugars in vivo, and we used the cancer cell's own internal mechanisms to do it,” said Cheng. Not only was Cheng’s team successful with cell cultures, they were able to claim success in mouse models of triple-negative breast cancer and colon cancer too.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 17, 2018
Cancer
JUL 17, 2018
Large Multifactorial NIH Study Announced for Prostate Cancer Aggressiveness in African-American Men
The largest coordinated study on Prostate cancer aims to look at both genetic and environmental factors that lead to increased risk and cancer aggressiveness in African-American men compared...
JUL 24, 2018
Cancer
JUL 24, 2018
Transfection, Transduction, and CRISPR...Oh My
CRISPR gene editing came about based on transfection and transduction type models of genetic transfer. There is potential for it to revolutionize gene editing but are there dangers lurking?...
AUG 21, 2018
Health & Medicine
AUG 21, 2018
First, They Came for the Straws...Now the Soda?
Bans on plastic straws and utensils are all over the news recently. While taking care of the planet is crucial, some critics say that banning plastic straw...
SEP 04, 2018
Cancer
SEP 04, 2018
Metal beads that could help reduce chemotherapy side effects in brain tumor
Brain tumors are one of the most challenging types of cancers to treat. Only 1 in 7 patients will survive the disease, and those survivors will usually suffer from lots of side effects becaus...
SEP 15, 2018
Cancer
SEP 15, 2018
Undescended testicles could lead to testicular cancer and infertility in adult males
An undescended testis (cryptorchidism) is a condition in which one of the testes or both have not descended into the right position in the scrotum at birth and either stay at the abdomen or d...
DEC 11, 2018
Cancer
DEC 11, 2018
Biosensors developed that can detect cancer's metastatic ability
Researchers in University of California San Diego School of Medicine have developed a biosensor that can detect whether a cancer cell will spread in the future or not, which will help in deve...
Loading Comments...